Schedule 13G ownership disclosure

NOVELION THERAPEUTICS, INC.

Security class unavailable · CUSIP: 67001K202

Event date: 2019-08-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,155,085
Percent of class
6.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-19-000451
Form type
SC 13G
Filer
NOVELION THERAPEUTICS INC.
CIK
CIK 827809
Filed
Aug 23, 2019
Reporting period
Aug 14, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub